Vivacelle Bio to Participate in BIO Partnering @ JPM Week 2025

Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, announced its participation in BIO Partnering @ JPM Week 2025 in San Francisco January 13-16.

During the event, Vivacelle's management team members will conduct one-on-one meetings with registered investors and potential partners, showcasing the company's business and clinical development strategy, recent corporate achievements, and anticipated milestones. 

KANSAS CITY, Mo., Jan. 9, 2025 /PRNewswire https://www.prnewswire.com/news-releases/vivacelle-bio-to-participate-in-bio-partnering--jpm-week-2025-302346322.html